Mediaplanet Partners up with NORD and Shaquem Griffin and more to help Raise Awareness for the Rare Disease Community
Ovid Therapeutics Inc. (OVID)
Last ovid therapeutics inc. earnings: 3/11 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.ovidrx.com
Company Research
Source: PR Web
NEW YORK (PRWEB) March 12, 2020 Mediaplanet recently announced the launch of the February 2020 edition of "Rare Diseases." This campaign will showcase the innovative work being done within rare diseases research, diagnostics, and will highlight what industry experts and patients see as potential future therapies for those living with rare diseases.Shaquem Griffin, the linebacker for the Seattle Seahawks, is the cover story of the print edition. Shaquem Griffin was born with a rare disease called amniotic band syndrome which is a rare condition caused by strands of the amniotic sac that separate and entangle digits, limbs, or other parts of the fetus. It's believed that amniotic band syndrome occurs when the inner membrane ruptures, or tears, without injury to the outer membrane. Shaquem speaks to the challenges he faced but with the support of his family and friends, and perseverance despite all odds he made it to the NFL and is now the fastest linebacker in the league. The print com
Show less
Read more
Impact Snapshot
Event Time:
OVID
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OVID alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OVID alerts
High impacting Ovid Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
OVID
News
- Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus' Post Grant Review [Yahoo! Finance]Yahoo! Finance
- Ovid Therapeutics Reaches US$197m Market Cap Benefiting Insider Stock Buying [Yahoo! Finance]Yahoo! Finance
- Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewswire
- Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care ConferenceGlobeNewswire
OVID
Earnings
- 3/8/24 - Miss
OVID
Sec Filings
- 3/20/24 - Form 4
- 3/8/24 - Form 10-K
- 3/8/24 - Form 8-K
- OVID's page on the SEC website